These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3755634)

  • 1. Molsidomine prevents post-ischaemic ventricular fibrillation in dogs.
    Cano JP; Guillen JC; Jouve R; Langlet F; Puddu PE; Rolland PH; Serradimigni A
    Br J Pharmacol; 1986 Aug; 88(4):779-89. PubMed ID: 3755634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by carbocromene and molsidomine against arrhythmias occurring during coronary artery occlusion and reperfusion in dogs.
    Fiedler VB; Kettenbach B; Göbel H; Nitz RE
    J Cardiovasc Pharmacol; 1985; 7(5):964-70. PubMed ID: 2413309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs.
    Fiedler VB
    Can J Physiol Pharmacol; 1982 Aug; 60(8):1104-11. PubMed ID: 6897011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of molsidomine in experimental models of ischemic cardiac disease.
    Nitz RE; Martorana PA
    Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cicletanide improves outcome after left circumflex coronary artery occlusion-reperfusion in the dog.
    Jouve R; Langlet F; Puddu PE; Rolland PH; Guillen JC; Cano JP; Serradimigni A
    J Cardiovasc Pharmacol; 1986; 8(1):208-15. PubMed ID: 2419686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischemic effects of molsidomine in an experimental model of coronary artery stenosis.
    Nitz RE; Mogilev AM; Göbel H
    Adv Myocardiol; 1983; 4():595-604. PubMed ID: 6687948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of molsidomine on spontaneous ventricular fibrillation following myocardial ischemia and reperfusion in the dog.
    Martorana PA; Mogilev AM; Kettenbach B; Nitz RE
    Adv Myocardiol; 1983; 4():605-13. PubMed ID: 6687949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of molsidomine on haemodynamics at rest and on exercise in patients who have coronary heart disease (author's transl)].
    Niehues B; Krimmel W; Hombach V; Tauchert M; Behrenbeck DW; Hilger HH
    Dtsch Med Wochenschr; 1978 May; 103(20):853-6. PubMed ID: 648365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.
    Martorana PA; Kettenbach B; Göbel H; Nitz RE
    Basic Res Cardiol; 1984; 79(5):503-12. PubMed ID: 6439183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1984 Apr; 81(4):675-84. PubMed ID: 6547068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of epoprostenol on ischemia-induced ventricular arrhythmias in dogs.
    Puddu PE; Langlet F; Lanti M; Guillen JC; Dawodu AA; Monti F; Schiariti M; Reale A
    Cardiologia; 1990 Jul; 35(7):551-9. PubMed ID: 2088600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs.
    Vegh A; Szekeres L; Parratt JR
    Br J Pharmacol; 1991 Oct; 104(2):294-5. PubMed ID: 1797297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
    Bussmann WD; Neidl K; Kaltenbach M
    Klin Wochenschr; 1982 Jan; 60(2):77-85. PubMed ID: 6896077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
    Silberbauer K; Slany J; Sinzinger H; Punzengruber C
    Z Kardiol; 1982 Aug; 71(8):539-43. PubMed ID: 6753382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of molsidomine and dopamine infusion on the size of canine experimental myocardial infarct.
    Fiedler VB; Buchheim S; Göbel H; Nitz RE
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):314-20. PubMed ID: 6897743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.